Skip to main content
Fig. 7 | Journal of Nanobiotechnology

Fig. 7

From: A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer

Fig. 7

In vivo concentration of butyric acid from BBA, BBA/CM-β-CD and BBA/FA-PEG-CM-β-CD at 3, 8, 12 h in the SW620 tumor-bearing nude mice. The significance of the differences was evaluated using 2-way ANOVA (*P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001). Data were shown as the mean ± SD in each group (n = 5)

Back to article page